Advertisement

Antimicrobial drugs with other modes of action

  • T. J. Franklin
  • G. A. Snow

Abstract

The antimicrobial agents described so far have been arranged together according to their primary effects on cellular metabolism and biosynthesis. This approach accounts for many of the most important drugs in current antimicrobial therapy. There are, however, several valuable drugs whose various modes of action fall outside those most commonly encountered. In this chapter we describe some important examples of compounds with unusual actions which we have arranged according to their therapeutic targets: antibacterial, antifungal, antiviral and antiprotozoal.

Keywords

Human Immunodeficiency Virus Antimicrobial Drug Antimalarial Action Human Immunodeficiency Virus Protease Variant Surface Glycoprotein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  1. Chaudhuri, A. R. and Ludena, R. F. (1996). Griseofulvin: a novel interaction with brain tubulin. Biochem. Pharmacol. 51, 903.CrossRefGoogle Scholar
  2. Cohen, J. L. (1996). Protease inhibitors: a tale of two companies. Science 171, 1882.CrossRefGoogle Scholar
  3. Dachs, G. V, Abatt, V R. and Woods, D. R. (1995). Mode of action of metronidazole and a Bacteroides fragilis meta resistance gene in Escherichia coli. J. Antimicroh. Chemother. 35, 483.CrossRefGoogle Scholar
  4. Egan, T. J., Ross, D. C. and Adams, P. A. (1994). Quinoline antimalarial drugs inhibit spontaneous formation of ß-haematin (malaria pigment). FEBS Letters 352, 54.CrossRefGoogle Scholar
  5. Fry, M. and Pudney, M. (1992). Site of action of the antimalarial hydroxynaphthoquinone, l[trans-4- (4’-chlorophenyl)cyclohexyl]-3-hydroxy-l,4-naph- thoquinone (566C80). Biochem. Pharmacol. 43, 1545.CrossRefGoogle Scholar
  6. Jefford, C. W. (1997). Peroxidic antimalarials. Drug Res. 29, 271.Google Scholar
  7. Pinto, L. H. (1995). Understanding the mechanism of the antiinfluenza drug amantadine. Trends Microbiol. 3, 271.CrossRefGoogle Scholar
  8. Sen, G. S. and Lengyell, P. (1992). The interferon system: a bird’s eye view of its biochemistry J. Biol. Chem. 167, 5017.Google Scholar
  9. Wang, C. C. (1995). Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. Ann. Rev. Pharmacol. Toxicol. 35, 93.CrossRefGoogle Scholar

Copyright information

© The Kluwer Academic Publishers 1998

Authors and Affiliations

  • T. J. Franklin
    • 1
  • G. A. Snow
    • 1
  1. 1.Zeneca PharmaceuticalsAlderley Park, Macclesfield, CheshireUK

Personalised recommendations